FXH Health Care AlphaDEX
- Health & Biotech Equities
FXH - Profile
- Issuer: First Trust
- Structure: ETF
- Expense Ratio: 0.66%
- ETF Home Page: FXH
- Inception: May 08, 2007
- Tax Form: 1099
- FXH Tracks This Index: StrataQuant Health Care Index
- 52 Week Lo: $51.50
- 52 Week Hi: $70.72
- AUM: $4,052.7 M
- Shares: 59.0 M
Alternative ETFs in the Health & Biotech Equities Category
|Type||Ticker||Expense Ratio||Assets||Avg. Daily Vol||YTD Return|
|Most Liquid (Volume)|
|Top YTD Performer|
The StrataQuant Health Care Index is an "enhanced" index developed, maintained and sponsored by the NYSE Euronext or its affiliates which employs the AlphaDEX stock selection methodology to select health care stocks from the Russell 1000 Index.
FXH - Realtime Rating
Realtime Rating Summary
FXH is a passive ETF that seeks to replicate StrataQuant Health Care Index. The StrataQuant Health Care Index is an "enhanced" index developed, maintained and sponsored by the NYSE Euronext or its affiliates which employs the AlphaDEX stock selection methodology to select health care stocks from the Russell 1000 Index.
The adjacent table gives investors an individual Realtime Rating for FXH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.
FXH In-Depth Analysis
The following tables and charts contain in-depth metrics for FXH and compare it to similar peer ETFs within its ETFdb Category.
FXH - HoldingsFilings Data as of: Jul 05, 2015
Top Ten Holdings
This section compares how balanced and deep FXH is relative to the peer group ETFdb Category.
FXH Asset Allocation
FXH Sector Breakdown
FXH Market Cap Breakdown
FXH Region Breakdown
FXH Market Tier Breakdown
FXH Country Breakdown
FXH - Expenses & Fees
This section compares the cost efficiency of FXH to peers in the same ETFdb Category.
Expenses Ratio Analysis
Commission Free Trading in FXH
FXH is not currently available for commission free trading on any platforms.
Category Commission Free Trading
There are 3 other ETFs in the Health & Biotech Equities ETFdb Category that are also eligible for commission free trading:
FXH - Performance
This section shows how FXH has performed relative to its peer group ETFdb Category.
FXH - Charts
The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.
The following chart also includes the option to compare the performance of FXH relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.
FXH - Technicals
FXH Volatility Analysis
This section shows how the volatility of FXH compares to the peer group ETFdb Category.
- 20 Day MA: $69.24
- 60 Day MA: $68.25
- MACD 15 Period: -1.28
- MACD 100 Period: 0.37
- Williams % Range 10 Day: 89.97
- Williams % Range 20 Day: 77.61
- RSI 10 Day: 36
- RSI 20 Day: 46
- RSI 30 Day: 49
- Ultimate Oscillator: 43
FXH Bollinger Bands
- Lower Bollinger (10 Day): $68.46
- Upper Bollinger (10 Day): $71.27
- Lower Bollinger (20 Day): $67.55
- Upper Bollinger (20 Day): $70.95
- Lower Bollinger (30 Day): $67.55
- Upper Bollinger (30 Day): $70.92
FXH Support & Resistance
- Support Level 1: $67.85
- Support Level 2: $67.58
- Resistance Level 1: $68.37
- Resistance Level 2: $68.62
- Stochastic Oscillator %D (1 Day): 44.11
- Stochastic Oscillator %D (5 Day): 32.33
- Stochastic Oscillator %K (1 Day): 48.94
- Stochastic Oscillator %K (5 Day): 50.52
Latest FXH News
ETF Picks For 3 Of The World's Most Innovative Companies
Forget AAPL, Find Some ISRG
AlphaDEX ETFs Turn In Impressive Performance
2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.